title: V0518

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is F
Chromosomal aberrations is 13q,12q
IgV mutation status is unmutated


title: V0572

status: Public on Apr 01 2005

type: RNA

city: Vienna

first: Stratowa

last: Christian

address: Dr. Boehringergasse 5-11

department: Dept NCE Lead Discovery

country: Austria

institute: Boehringer Ingelheim Austria

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is 13q,17p
IgV mutation status is unmutated

molecule: total RNA

organism: Homo sapiens

source_name: Peripheral blood lymphocytes


title: V0517

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is F
Chromosomal aberrations is 13q
IgV mutation status is mutated


title: V0512

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is F
Chromosomal aberrations is none
IgV mutation status is mutated


title: V0525

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is 13q
IgV mutation status is mutated


title: V0567

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is 13q,11q
IgV mutation status is unmutated


title: V0521

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is 13q,12q
IgV mutation status is unmutated


title: V0511

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is F
Chromosomal aberrations is 13q,12q
IgV mutation status is mutated


title: V0519


title: V0506


title: V0508

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is F
Chromosomal aberrations is 17p,t14
IgV mutation status is unmutated


title: V0502

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is none
IgV mutation status is mutated


title: V0503

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is 13q
IgV mutation status is unmutated


title: V0509

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is F
Chromosomal aberrations is none
IgV mutation status is unmutated


title: V0500


title: V0505


title: V0510


title: V0504

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is F
Chromosomal aberrations is 12q
IgV mutation status is mutated


title: V0501


title: V0497


title: V0498


title: V0493

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is none
IgV mutation status is unmutated


title: V0495

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is 13q,11q,6q
IgV mutation status is unmutated


title: V0496


title: V0499

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is 12q
IgV mutation status is mutated


title: V0491

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is F
Chromosomal aberrations is 13q
IgV mutation status is unmutated


title: V0492


title: V0490

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is F
Chromosomal aberrations is 6q
IgV mutation status is unmutated


title: V0489


title: V0494


title: V0488


title: V0486

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is F
Chromosomal aberrations is 11q
IgV mutation status is unmutated


title: V0487


title: V0484


title: V0482


title: V0483

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is 13q,14t18
IgV mutation status is mutated


title: V0481

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is F
Chromosomal aberrations is 12q
IgV mutation status is unmutated


title: V0477

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is F
Chromosomal aberrations is 13q
IgV mutation status is mutated


title: V0476


title: V0478

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is F
Chromosomal aberrations is none
IgV mutation status is mutated


title: V0470


title: V0479

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is 13q
IgV mutation status is mutated


title: V0473

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is Control sample
Gender is unknown
Chromosomal aberrations is n.a.
IgV mutation status is n.a.


title: V0465


title: V0467

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is F
Chromosomal aberrations is 13q,12q
IgV mutation status is mutated


title: V0471


title: V0475

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is none
IgV mutation status is mutated


title: V0472


title: V0474


title: V0468


title: V0469


title: V0480

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is 12q
IgV mutation status is unmutated


title: V0464

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is 13q
IgV mutation status is unmutated


title: V0462


title: V0466


title: V0461

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is 13q,17p
IgV mutation status is unmutated


title: V0457

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is 13q,11q
IgV mutation status is mutated


title: V0459

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is none
IgV mutation status is unmutated


title: V0460

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is 13q,17p
IgV mutation status is mutated


title: 052401_HF_291FL

status: Public on Mar 10 2005

city: La Jolla

first: Steven

last: Head

state: CA

address: 10550 N Torrey Pines Rd

country: USA

institute: The Scripps Research Institute

description:
tissue sample collected post mortem from SIV infected rhesus macaques 93-102 weeks post infection
full description of sample found in: Roberts ES, Burudi EM, Flynn C, Madden LJ, Roinick KL, Watry DD, Zandonatti MA, Taffe MA, Fox HS. (2004). Acute SIV infection of the brain leads to upregulation of IL6 and interferon-regulated genes: expression patterns throughout disease progression and impact on neuroAIDS. J Neuroimmunol. Dec;157(1-2):81-92.
Keywords = SIV, NeuroAIDS, frontal lobe, encephalitis, AIDS, rhesus

organism: Macaca mulatta

source_name: frontal lobe


title: V0463


title: 060501_HF_290FL


title: 052401_HF_290FL


title: V0458


title: 060501_HF_291FL


title: 032801_HF_354FL

description:
tissue sample collected post mortem from SIV infected rhesus macaques eleven weeks post infection
full description of sample found in: Roberts ES, Burudi EM, Flynn C, Madden LJ, Roinick KL, Watry DD, Zandonatti MA, Taffe MA, Fox HS. (2004). Acute SIV infection of the brain leads to upregulation of IL6 and interferon-regulated genes: expression patterns throughout disease progression and impact on neuroAIDS. J Neuroimmunol. Dec;157(1-2):81-92.
Keywords = SIV, NeuroAIDS, frontal lobe, encephalitis, AIDS, rhesus


title: 042601_HF_352FL


title: 060501_HF_304FL


title: 042601_HF_353FL


title: 052401_HF_304FL


title: 072303_HF_430FL

description:
tissue sample collected post mortem from SIV infected rhesus macaques two weeks post infection
full description of sample found in: Roberts ES, Burudi EM, Flynn C, Madden LJ, Roinick KL, Watry DD, Zandonatti MA, Taffe MA, Fox HS. (2004). Acute SIV infection of the brain leads to upregulation of IL6 and interferon-regulated genes: expression patterns throughout disease progression and impact on neuroAIDS. J Neuroimmunol. Dec;157(1-2):81-92.
Keywords = SIV, NeuroAIDS, frontal lobe, encephalitis, AIDS, rhesus


title: 042601_HF_354FL


title: 042601_HF_350FL


title: 032901_HF_350FL


title: 032901_HF_353FL


title: V0455

description:
Mononuclear cells were isolated using Ficoll gradient. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. The MAS5 algorithm as implemented in the Bioconductor package simpleaffy_2.10 was used to convert raw data to expression values and detection calls.
Chip type is HG-U95Av2
Sample type is B-CLL sample
Gender is M
Chromosomal aberrations is 17p
IgV mutation status is unmutated


title: 072203_HF_430FL


title: 032801_HF_352FL


title: 082101_HF_347FL


title: 081401_HF_347FL


title: 060501_HF_335FL


title: 082101_HF_346FL


title: 708 G4

status: Public on Mar 09 2005

city: Chicago

first: M Rosario

last: Hernandez

state: IL

address: 330 Chicago Avenue

department: Ophthalmology

institute: Northwestern University

description: Astrocytes from optic nerve head of 83-year-old man with glaucoma, right eye

source_name: Primary Optic nerve head astrocytes


title: 052401_HF_335FL


title: 7239 N410

description: Astrocytes from optic nerve head of 65-year-old man without glaucoma, left eye

source_name: Primary optic nerve head astrocytes


title: 7234 G43

description: Astrocytes from optic nerve head of 80-year-old woman with glaucoma, left eye


title: 7235 G45

description: Astrocytes from optic nerve head of 79-year-old woman with glaucoma, left eye


title: VADS_0829_T_M

city: Illkirch

first: Annaïck

last: Carles

country: France

institute: IGBMC

description: Hypopharyngeal cancer. Patient = 0829. M=Metastasis. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer 2004).Total RNA were extracted using Qiagen RNeasy kit and treated with DNAse.


title: 747 N3

description: Astrocytes from optic nerve head of 46-year-old man, left eye


title: 081401_HF_346FL


title: VADS_0744_T_M

description: Hypopharyngeal cancer. Patient = 0744. M=Metastasis. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer 2004).Total RNA were extracted using Qiagen RNeasy kit and treated with DNAse.


title: 707 G3

description: Astrocytes from optic nerve head of 83-year-old man with glaucoma, left eye


title: 7236 G48

description: Astrocytes from optic nerve head of 72-year-old woman with glaucoma, A eye


title: 705 N2

description: Astrocytes from optic nerve head of 55-year-old woman, right eye


title: 7238 N49

description: Astrocytes from optic nerve head of 72-year-old woman without glaucoma, left eye


title: 7233 G42

description: Astrocytes from optic nerve head of 69-year-old man with glaucoma, right eye


title: 748 N4

description: Astrocytes from optic nerve head of 65-year-old man, right eye


title: 706 G2

description: Astrocytes from optic nerve head of 56-year-old woman with glaucoma, right eye


title: VADS_0847_T_NM

description: Hypopharyngeal cancer. Patient = 0847. NM=no Metastasis. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer 2004).Total RNA were extracted using Qiagen RNeasy kit and treated with DNAse.


title: VADS_0702_T_LR

description: Hypopharyngeal cancer. Patient = 0702. LR=Local recurrence. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer 2004).Total RNA were extracted using Qiagen RNeasy kit and treated with DNAse.


title: VADS_0330_T_M

description: Hypopharyngeal cancer. Patient 0330. M=Metastatic. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer 2004).Total RNA were extracted using Qiagen RNeasy kit and treated with DNAse.


title: VADS_0357_T_NM

description:
Patient number = 0357. NM= no-metastasis.
A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer 2004).Total RNA were extracted using Qiagen RNeasy kit and treated with DNAse.


title: VADS_0684_T_LR

description: Hypopharyngeal cancer. Patient = 0684. LR=Local recurrence. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer 2004).Total RNA were extracted using Qiagen RNeasy kit and treated with DNAse.


title: VADS_0409_T_NM

description: Hypopharyngeal cancer. Patient number = 0409. NM=no metastatic. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer 2004).Total RNA were extracted using Qiagen RNeasy kit and treated with DNAse.


title: VADS_0215_T_M

description: Hypopharyngeal cancer. Patient 0215. M=metastatic. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer 2004).Total RNA were extracted using Qiagen RNeasy kit and treated with DNAse.


title: VADS_0423_T_NM

description: Hypopharyngeal cancer. Patient = 0423. NM=No metastatic. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer 2004).Total RNA were extracted using Qiagen RNeasy kit and treated with DNAse.


title: VADS_0203_T_M

description: Hypopharyngeal cancer. Patient 0203. M= metastatic. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer 2004).Total RNA were extracted using Qiagen RNeasy kit and treated with DNAse.


title: 052401_HF_321CB

status: Public on Mar 08 2005

description:
tissue sample collected post mortem from SIV infected rhesus macaques
full description of sample found in Roberts ES, Zandonatti MA, Watry DD, Madden LJ, Henriksen SJ, Taffe MA, Fox HS. (2003) Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS. Am J Pathol. Jun;162(6):2041-57.
Keywords = HIV, NeuroAIDS, brain, encephalitis, AIDS, rhesus macaques, SIV

source_name: cerebellum


title: VADS_0408_T_M

description: Hypopharyngeal cancer. Patient number = 0408. M= metastasis. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer 2004).Total RNA were extracted using Qiagen RNeasy kit and treated with DNAse.


title: VADS_0118_T_LR

description: Hypopharyngeal cancer. Patient 0118. LR=Local Recurrence. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer et al. 2004)


title: VADS_0629_T_M

description: Hypopharyngeal cancer. Patient = 0629. M=metastasis. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer 2004).Total RNA were extracted using Qiagen RNeasy kit and treated with DNAse.


title: VADS_0103_T_NM

description: Hypopharyngeal cancer. Patient : 0103. NM=No metastatic tumor. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer et al. Oncogene. 2004 Apr 1;23(14):2484-98.PMID: 14676830)


title: 070302_HF_328CB


title: 070302_HF_301CB


title: VADS_0621_T_M

description: Hypopharyngeal cancer. Patient = 0621. M=metastasis. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer 2004).Total RNA were extracted using Qiagen RNeasy kit and treated with DNAse.


title: VADS_0165_T_M

description: Hypopharyngeal cancer. Patient 0165. M= Metastasic. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer 2004).Total RNA were extracted using Qiagen RNeasy kit and treated with DNAse.


title: 071202_HF_289CB


title: VADS_0167_T_NM

description: Hypopharyngeal cancer. Patient 0167. NM=no metastatic. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer 2004).Total RNA were extracted using Qiagen RNeasy kit and treated with DNAse.


title: VADS_0218_T_M

description: Hypopharyngeal cancer. Patient 0218. M=metastatic. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer 2004).Total RNA were extracted using Qiagen RNeasy kit and treated with DNAse.


title: VADS_0429_T_LR

description: Hypopharyngeal cancer. Patient = 0429. LR=Local recurrence. A full description of the clinical data, including diagnosis and outcome is shown in Table 1 (Cromer 2004).Total RNA were extracted using Qiagen RNeasy kit and treated with DNAse.


title: 052401_HF_323CB


title: 052401_HF_357CB

description:
tissue sample collected post mortem from control rhesus macaques (not SIV infected)
full description of sample found in Roberts ES, Zandonatti MA, Watry DD, Madden LJ, Henriksen SJ, Taffe MA, Fox HS. (2003) Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS. Am J Pathol. Jun;162(6):2041-57.
Keywords = HIV, NeuroAIDS, brain, encephalitis, AIDS, rhesus macaques, SIV


title: 052401_HF_332CB


title: 111601_HF_393CB


title: 071202_HF_328MB

source_name: midbrain


title: 032801_HF_332MB


title: 032801_HF_321MB


title: 032801_HF_298MB


title: 041101_HF_330VC

source_name: Occipital Lobe (Visual Cortex)


title: 070302_HF_301MB


title: 052401_HF_298CB


title: 070302_HF_301VC


title: 111601_HF_393VC


title: 041101_HF_321VC


title: 070302_HF_331MB


title: 052401_HF_331CB


title: 051801_HF_331VC


title: 070302_HF_289MB


title: 041101_HF_323VC


title: 032801_HF_357MB


title: 042601_HF_330FL


title: 032801_HF_330FL


title: 013102_HF_328FL


title: 042601_HF_323FL


title: 020102_HF_328FL


title: 021301_HF_321FL


title: 020102_HF_289FL


title: 020602_HF_301FL


title: 042601_HF_321FL


title: 020502_HF_301FL


title: 112101_HF_393FL


title: 080201_HF_392Fl


title: 021301_HF_357FL


title: 042601_HF_357FL


title: 021301_HF_323FL


title: 111601_HF_393FL


title: 052201_HF_331FL


title: 080301_HF_392Fl


title: 051801_HF_331FL


title: 042601_HF_332FL


title: PB-MIGR1.3

status: Public on Mar 01 2005

city: New York

first: Agnes

last: Viale

state: NY

address: 1275 York Avenue

department: Molecular Biology

institute: Memorial Sloan Kettering Cancer Center

description:
MIGR1 Transduced CD 34 cells- not selected after transduction
Keywords = MIGR1

source_name: Total RNA


title: 021301_HF_332FL


title: PB-AE.3

description:
AML1-ETO Transduced CD 34 cells- not selected after transduction
Keywords = AML1-ETO


title: 021301_HF_298FL


title: 013102_HF_289FL


title: 042601_HF_298FL


title: CB-AE


title: CB-MIGR1

description:
EMPTY VECTOR Transduced CD 34 cells- not selected after transduction
Keywords = MIGR1


title: LEP Sca1+ve - Liver Endothelial Progenitor Sca1+ve cells

first: Sunil

last: Kurian

address: 10550 N Torrey Pines Road

department: Molecular and Experimental Medicine

description: While others have reported that fetal liver contains a population of endothelial progenitors based on expression of cell surface markers or culture assays, this is the first proof of a CD31+Sca1+ progenitor by demonstrating highly efficient in vivo angiogenesis and a direct connection to the host vasculature. We have developed a novel isolation method based on collagenase digestion and culture on a fetal liver-derived feeder layer and demonstrate that the feeder cells or their supernatants are required for endothelial progenitor survival and proliferation. Proteogenomic profiling of the endothelial progenitors and the feeder cells was done with tandem mass spectrometry proteomics using MudPIT and gene transcript expression profiling using high density DNA microarrays. This approach identified a number of gene transcripts, proteins and candidate growth factor pathways that are likely to be involved in endothelial progenitor growth, differentiation and angiogenesis.

organism: Mus musculus

source_name: Fetal Liver


title: Cryptosporidium parvum-infected HCT-8 cells, time course 3, 12h

status: Public on Feb 15 2005

city: Saint Paul

first: Mingqi

last: Deng

state: MN

address: 1988 Fitch Avenue

department: Veterinary and Biomedical Sciences

institute: University of Minnesota

description: • The origin of biological samples (In vitro infection of HCT-8 cells with Cryptosporidium parvum)


title: Cryptosporidium parvum-infected HCT-8 cells, time course 3, 48h


source_name: Cryptosporidium parvum-infected HCT-8 cells, time course 3, mock (24h post-infection)


title: Cryptosporidium parvum-infected HCT-8 cells, time course 2, 48h


title: Cryptosporidium parvum-infected HCT-8 cells, time course 2, 72h


title: Cryptosporidium parvum-infected HCT-8 cells, time course 3, 72h


title: LEP - Liver Endothelial Progenitor (Mus musculus)


title: Cryptosporidium parvum-infected HCT-8 cells, time course 3, 6h


title: Cryptosporidium parvum-infected HCT-8 cells, time course 2, 24h


title: Cryptosporidium parvum-infected HCT-8 cells, time course 2, 6h


source_name: Cryptosporidium parvum-infected HCT-8 cells, time course 2, mock (24h post-infection)


title: Cryptosporidium parvum-infected HCT-8 cells, time course 3, 24h


title: Cryptosporidium parvum-infected HCT-8 cells, time course 1, 48h


title: Cryptosporidium parvum-infected HCT-8 cells, time course 2, 12h


title: Cryptosporidium parvum-infected HCT-8 cells, time course 1, 24h


title: Cryptosporidium parvum-infected HCT-8 cells, time course 1, 12h


title: Cryptosporidium parvum-infected HCT-8 cells, time course 1, 72h


title: Cryptosporidium parvum-infected HCT-8 cells, time course 1, 6h


description:
• The origin of biological samples (In vitro infection of HCT-8 cells with Cryptosporidium parvum)

Monolayers of the HCT-8 cells (ATCC CCL-244, American Type Culture Collection) were cultured in RPMI 1640 medium containing 10% fetal bovine serum and additional nutritional supplements. Cells in log phase were plated at 2×106 cells per 150 mm tissue culture dish and infected with sterilised Cryptosporidium parvum oocysts (Iowa strain). Purified oocysts were suspended in phosphate buffered saline, sterilised in 33% bleach for 7 min on ice, washed in Hank's buffered saline solution, and added to HCT-8 cultures at a ratio of one oocyst per cell. Following a 2 h excystation period at 37 °C, cells were washed with warm Hank's buffered saline solution, and cells were incubated in fresh supplemented media. Mock-infected cultures were treated identically, with the exception that oocysts were not added to the cultures.

Three independent mock- and C. parvum-infected cultures were prepared for analysis.

• The origin of mRNA samples

At 6, 12, 24, 48, and 72h post-inoculation, cell culture media were removed and cultures were immediately lysed by the addition of 3.5 ml of Trizol® reagent (GIBCO BRL Life Technologies) directly to the culture plate. Total RNA was prepared as described by the manufacturer, and poly(A) mRNA was isolated using oligo-dT cellulose columns (Amersham Pharmacia Biotech). The qualities of total RNA and poly(A) mRNA preparations were assessed by Northern blot.

• Protocols for conducting microarray hybridization

Poly(A) mRNA was converted into ‘target’ suitable for hybridisation to Affymetrix microarray chips according to protocols provided by Affymetrix Inc. (Santa Clara, CA). Briefly, 2.0 g of poly(A) mRNA was reverse-transcribed to prepare double-stranded cDNA using T7-(dT)24 primer (GENSET Corp., La Jolla, CA) and Superscript II reverse transcriptase (GIBCO). Approximately 1 g of cDNA was used for in vitro transcription in the presence of biotinylated UTP and CTP using the Enzo BioArray High Yield RNA Transcript Labelling Kit (Enzo Diagnostics, Inc). This labelled cRNA was fragmented in 40 mM Tris–acetate (pH 8.1), 100 mM potassium acetate, and 30 mM magnesium acetate at 94 °C for 35 min. The integrity of cRNA and the efficiency of fragmentation were monitored by Northern blot analysis (not shown).
Fragmented biotinylated cRNA targets were hybridised to HG-U95Av2 chips (Affymetrix) that contain probe sets for 12,600 human gene/transcripts. Fifteen micrograms of fragmented cRNA and appropriate controls were hybridised to the chips at 45 °C for 16 h with constant rotation at 60 rev./min. The chips were subsequently washed and stained with streptavidin–phycoerythrin conjugate using the GeneChip Fluidics station protocol EukGE_WS2 (Affymetrix). Following washing and staining, microarray chips were scanned twice at 3 m resolution using a Hewlett-Packard confocal scanner and hybridisation intensities for each of the genes/transcripts were collected from scanned images.

• Analysis of microarray data

Gene expression data were initially analysed with the GeneChip® expression analysis software (Affymetrix Microarray Suite, version 5.0). The fluorescence intensity of the genes/transcripts was measured for each probe array and, to minimise discrepancies due to non-biological variations, normalised by global scaling to 1000.

Further data analyses were performed using GeneSpring software (version 6.0; Silicon Genetics, Redwood City, CA). Per gene normalisation was applied in which the expression signal of each gene in C. parvum-infected cells (raw data) was normalised to the median of its measurements in the mock-infected samples (control); and the ratio of expression levels between mock and infected samples was calculated as the mean value of normalised signal vs. control signal among three replicates. To identify genes with significantly altered expression, a series of statistical analyses (filtering) were performed: cut-off values for ratio of expression levels 1.80 and 0.55 were used to filter genes with expression level fold changes greater than ±1.8 in all three independent samples. Genes with fold change variations >1.5 across the three samples were excluded. Furthermore, a ‘statistical group comparison’ using Student's t-test/ANOVA was conducted to compare mean expression levels between mock-infected and infected samples, and the genes with significant differential expression (P<0.05) were selected. Identified differentially expressed genes were then annotated using GeneSpring's ‘Build Simplified Ontology’ constructor which hierarchically groups genes into meaningful biological categories (gene lists) based on the Gene Ontology Consortium Classifications. Various lists of regulated genes were created by cross-referencing annotated gene lists and applying assorted statistical methods.

source_name: Cryptosporidium parvum-infected HCT-8 cells, time course 1, mock (24h post-infection)


title: LEP Sca1-ve - Liver Endothelial Sca1-ve Cells


title: normal bone marrow NBM3

status: Public on Jan 28 2005

city: Tokyo

first: Hitoshi

last: Ichikawa

address: 5-1-1 Tsukiji, Chuo-ku

country: Japan

institute: National Cancer Center Research Institute

description: normal bone marrow

source_name: mononuclear cells isolated from bone marrow


title: normal bone marrow NBM4

description: normal bone marrow


title: pediatric AML S36

description: pediatric AML M2

source_name: mononuclear cells isolated from peripheral blood or bone marrow


title: normal bone marrow NBM2

description: normal bone marrow


title: normal bone marrow NBM1

description: normal bone marrow


title: pediatric AML S35

description: pediatric AML M5


title: pediatric AML S27

description: pediatric AML M7


title: pediatric AML S32

description: pediatric AML M5


title: pediatric AML S31

description: pediatric AML M7


title: pediatric AML S26

description: pediatric AML M4


title: pediatric AML S25

description: pediatric AML M5


title: pediatric AML S28

description: pediatric AML M5


title: pediatric AML S33

description: pediatric AML M7


title: pediatric AML S24

description: pediatric AML M5


title: pediatric AML S30

description: pediatric AML M0


title: pediatric AML S23

description: pediatric AML M5


title: pediatric AML S29

description: pediatric AML M5


title: pediatric AML S22

description: pediatric AML M5


title: pediatric AML S19

description: pediatric AML M4


title: pediatric AML S34

description: pediatric AML M5


title: pediatric AML S20

description: pediatric AML M5


title: pediatric AML S18

description: pediatric AML M7


title: pediatric AML S21

description: pediatric AML M4


title: pediatric AML S17

description: pediatric AML M5


title: pediatric AML S16

description: pediatric AML M4


title: pediatric AML S14

description: pediatric AML M2


title: pediatric AML S11

description: pediatric AML M2


title: pediatric AML S13

description: pediatric AML M5


title: pediatric AML S06

description: pediatric AML M7


title: pediatric AML S10

description: pediatric AML M5


title: pediatric AML S08

description: pediatric AML M7


title: pediatric AML S12

description: pediatric AML M4


title: pediatric AML S04

description: pediatric AML M2


title: pediatric AML S05

description: pediatric AML M5


title: pediatric AML S15

description: pediatric AML M2


title: pediatric AML S03

description: pediatric AML M5


title: pediatric AML S09

description: pediatric AML M4


title: pediatric AML PP5

description: pediatric AML M7


title: pediatric AML PP7

description: pediatric AML M5


title: pediatric AML PP9

description: pediatric AML M2


title: pediatric AML S01

description: pediatric AML M2


title: pediatric AML PP8

description: pediatric AML M7


title: pediatric AML PP6

description: pediatric AML M2


title: pediatric AML S07

description: pediatric AML M2


title: pediatric AML GP9

description: pediatric AML M2


title: pediatric AML GP3

description: pediatric AML M2


title: pediatric AML GP8

description: pediatric AML M4


title: pediatric AML PP1

description: pediatric AML M4


title: pediatric AML PP3

description: pediatric AML M5


title: pediatric AML GP5

description: pediatric AML M4


title: pediatric AML S02

description: pediatric AML M5


title: pediatric AML PP2

description: pediatric mixed lineage leukemia


title: pediatric AML GP2

description: pediatric AML M4


title: pediatric AML GP7

description: pediatric AML M4


title: pediatric AML PP4

description: pediatric mixed lineage leukemia


title: pediatric AML GP1

description: pediatric AML M4


title: pediatric AML GP4

description: pediatric AML M2


title: M_95Av2_3108_DLPFC_0_GS

city: Irvine

first: Marquis

last: Vawter

address: Gillespie Neuroscience, Room 2119

department: Psychiatry and Human Behavior

institute: University of California, Irvine

description:
Site: University of Michigan
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.12
Subject: 3108
Gender: Female
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.

source_name: Brain region: DLPFC (dorsolateral prefrontal cortex)


title: pediatric AML GP6

description: pediatric AML M5


title: I_95Av2_3076_DLPFC_1_GS

description:
Site: University of California, Irvine
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.49
Subject: 3076
Gender: Male
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: I_95Av2_3076_CB_1_GS

source_name: Brain region: CB (cerebellum)


title: M_95Av2_3076_DLPFC_1_GS

description:
Site: University of Michigan
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.49
Subject: 3076
Gender: Male
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: I_95Av2_3076_AnCg_1_GS

source_name: Brain region: AnCg (anterior cingulate cortex)


title: D_95Av2_3108_DLPFC_0_GS

description:
Site: University of California, Davis
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.12
Subject: 3108
Gender: Female
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: I_95Av2_3108_AnCg_0_GS

description:
Site: University of California, Irvine
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.12
Subject: 3108
Gender: Female
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: I_95Av2_3023_DLPFC_0_GS

description:
Site: University of California, Irvine
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.71
Subject: 3023
Gender: Female
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: D_95Av2_3108_AnCg_0_GS


title: I_95Av2_3023_CB_0_GS


title: I_95Av2_3023_Cg_0_GS


title: M_95Av2_3023_DLPFC_0_GS

description:
Site: University of Michigan
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.71
Subject: 3023
Gender: Female
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: I_95Av2_3108_CB_0_GS


title: I_95Av2_3108_DLPFC_0_GS


title: D_95Av2_3023_CB_0_GS

description:
Site: University of California, Davis
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.71
Subject: 3023
Gender: Female
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: D_95Av2_3076_CB_1_GS

description:
Site: University of California, Davis
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.49
Subject: 3076
Gender: Male
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: D_95Av2_3108_CB_0_GS


title: M_95Av2_2978_DLPFC_0_GS

description:
Site: University of Michigan
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.4
Subject: 2978
Gender: Female
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: I_95Av2_1871_CB_0_GS

description:
Site: University of California, Irvine
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.13
Subject: 1871
Gender: Female
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: D_95Av2_3023_Cg_0_GS


title: D_95Av2_3076_DLPFC_1_GS


title: I_95Av2_2978_DLPFC_0_GS

description:
Site: University of California, Irvine
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.4
Subject: 2978
Gender: Female
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: D_95Av2_3023_DLPFC_0_GS


title: D_95Av2_2846_DLPFC_1_GS

description:
Site: University of California, Davis
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.43
Subject: 2846
Gender: Male
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: I_95Av2_2978_CB_0_GS


title: I_95Av2_2846_CB_1_GS

description:
Site: University of California, Irvine
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.43
Subject: 2846
Gender: Male
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: D_95Av2_2978_DLPFC_0_GS

description:
Site: University of California, Davis
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.4
Subject: 2978
Gender: Female
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: I_95Av2_2835_AnCg_1_GS

description:
Site: University of California, Irvine
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.84
Subject: 2835
Gender: Male
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: D_95Av2_2835_CB_1_GS

description:
Site: University of California, Davis
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.84
Subject: 2835
Gender: Male
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: I_95Av2_2835_DLPFC_1_GS


title: M_95Av2_2846_DLPFC_1_GS

description:
Site: University of Michigan
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.43
Subject: 2846
Gender: Male
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: I_95Av2_2978_AnCg_0_GS


title: D_95Av2_2978_CB_0_GS


title: D_95A_1905_CB_1_GS

description:
Site: University of California, Davis
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.94
Subject: 1905
Gender: Male
Chip: Affymetrix GeneChip Human Genome U95A
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: I_95Av2_2822_Cg_1_GS

description:
Site: University of California, Irvine
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.86
Subject: 2822
Gender: Male
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: I_95Av2_2846_AnCg_1_GS


title: I_95Av2_2846_DLPFC_1_GS


title: M_95A_3108_AnCg_0_GS

description:
Site: University of Michigan
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.12
Subject: 3108
Gender: Female
Chip: Affymetrix GeneChip Human Genome U95A
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: I_95Av2_2822_CB_1_GS


title: I_95Av2_1871_Cg_0_GS


title: M_95A_1871_DLPFC_0_GS

description:
Site: University of Michigan
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.13
Subject: 1871
Gender: Female
Chip: Affymetrix GeneChip Human Genome U95A
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: M_95A_3076_CB_1_GS

description:
Site: University of Michigan
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.49
Subject: 3076
Gender: Male
Chip: Affymetrix GeneChip Human Genome U95A
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: D_95Av2_2846_CB_1_GS


title: M_95Av2_2835_DLPFC_1_GS

description:
Site: University of Michigan
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.84
Subject: 2835
Gender: Male
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: M_95A_3076_AnCg_1_GS


title: M_95A_1871_CB_0_GS


title: I_95Av2_2835_CB_1_GS


title: I_95Av2_2822_DLPFC_1_GS


title: M_95A_2978_CB_0_GS

description:
Site: University of Michigan
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.4
Subject: 2978
Gender: Female
Chip: Affymetrix GeneChip Human Genome U95A
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: D_95Av2_2835_AnCg_1_GS


title: D_95Av2_2822_Cg_1_GS

description:
Site: University of California, Davis
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.86
Subject: 2822
Gender: Male
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: M_95A_3108_CB_0_GS


title: M_95A_1871_Cg_0_GS


title: M_95A_3023_Cg_0_GS

description:
Site: University of Michigan
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.71
Subject: 3023
Gender: Female
Chip: Affymetrix GeneChip Human Genome U95A
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: I_95Av2_2822_AnCg_1_GS_B


title: M_95A_3023_CB_0_GS


title: M_95A_2835_AnCg_1_GS

description:
Site: University of Michigan
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.84
Subject: 2835
Gender: Male
Chip: Affymetrix GeneChip Human Genome U95A
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: M_95A_2978_AnCg_0_GS


title: M_95A_2822_Cg_1_GS

description:
Site: University of Michigan
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.86
Subject: 2822
Gender: Male
Chip: Affymetrix GeneChip Human Genome U95A
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: I_95Av2_2672_Cg_0_GS

description:
Site: University of California, Irvine
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.98
Subject: 2672
Gender: Female
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: D_95Av2_1871_Cg_0_GS

description:
Site: University of California, Davis
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.13
Subject: 1871
Gender: Female
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: D_95Av2_2822_DLPFC_1_GS


title: D_95Av2_2672_Cg_0_GS

description:
Site: University of California, Davis
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.98
Subject: 2672
Gender: Female
Chip: Affymetrix GeneChip Human Genome U95A Version 2
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: M_95A_2846_CB_1_GS

description:
Site: University of Michigan
Cohort: Male/Female Control Set
Diagnosis: Control
pH: 6.43
Subject: 2846
Gender: Male
Chip: Affymetrix GeneChip Human Genome U95A
We appreciate the assistance of Richard Stein, Ph.D. and Preston Cartagena, Psy.D. for their contributions to postmortem clinical characterization of subjects.  We acknowledge Kathleen Burke as well as Jacque Berndt and the investigators and medical examiners at the Orange County Coroners Office for procurement of brain tissue.  We also appreciate the technical contributions of Kevin Overman, Sharon Burke, and Phong Nguyen.  F. Warren Lovell, M.D, performed a neuropathological evaluation of the postmortem brains.  Tissue specimens were processed and stored at the Human Brain and Spinal Fluid Resource Center, Veteran's Medical Center, Los Angeles under the direction of Wallace W. Tourtellotte, M.D., Ph.D.  This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Neuropsychiatric Disorders Research Consortium, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA).  The authors are members of of a Conte Center supported by the NIMH and the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, the University of California, and Stanford University to encourage the development of appropriate findings for research and clinical applications.


title: M_95A_2846_AnCg_1_GS


title: M_95A_2835_CB_1_GS